Showing results (21-30 of 160) with videos related to
Sort By:
Pageof 16
Therapeutic Advances in Neurological Disorders|April 7, 2018
Defining distinct features of anti-MOG antibody associated central nervous system demyelinationMartin S Weber, Tobias Derfuss, Imke Metz, et al.Multiple Sclerosis and Related Disorders|March 23, 2019
A case of concomitant psoriasis and multiple sclerosis: Secukinumab and rituximab exert dichotomous effects in two autoimmune conditionsMartin Diebold, Simon Müller, Tobias Derfuss, et al.International Journal of Molecular Sciences|July 22, 2015
B Cells and Autoantibodies in Multiple SclerosisAnne-Katrin Pröbstel, Nicholas S R Sanderson, Tobias DerfussInternational Journal of Molecular Sciences|April 5, 2017
Expression of the Antioxidative Enzyme Peroxiredoxin 2 in Multiple Sclerosis Lesions in Relation to InflammationDavid Voigt, Uta Scheidt, Tobias Derfuss, et al.Annals of the New York Academy of Sciences|August 4, 2009
The presence of lytic HSV-1 transcripts and clonally expanded T cells with a memory effector phenotype in human sensory gangliaTobias Derfuss, Viktor Arbusow, Michael Strupp, et al.Multiple Sclerosis and Related Disorders|September 9, 2015
Optimizing treatment initiation: Effects of a patient education program about fingolimod treatment on knowledge, self-efficacy and patient satisfactionAndrea Zimmer, Cornelia Bläuer, Michael Coslovsky, et al.Journal of the Neurological Sciences|August 22, 2008
Compartmentalization of inflammation in the CNS: a major mechanism driving progressive multiple sclerosisEdgar Meinl, Markus Krumbholz, Tobias Derfuss, et al.Multiple Sclerosis and Related Disorders|July 27, 2016
Relapse rates in patients with multiple sclerosis treated with fingolimod: Subgroup analyses of pooled data from three phase 3 trialsTobias Derfuss, Daniel Ontaneda, Jacqueline Nicholas, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|November 14, 2014
A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patientsTobias Derfuss, François Curtin, Claudia Guebelin, et al.Journal of Neuroimmunology|July 23, 2015
A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - a twelve month follow-upTobias Derfuss, François Curtin, Claudia Guebelin, et al.Pageof 16